LobbyingHealthcare Distribution Alliance lobbying by quarter
Healthcare Distribution Alliance's latest lobbying report covers Q2 2026, at $90K. The four quarters Q4 2025–Q3 2026 total $290K. Its first report covers Q4 2022; the issues it reports most are Pharmacy and Health Issues.
Healthcare Distribution Alliance
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $290K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $60K | 1 |
| Q1 2023 | $60K | 1 |
| Q2 2023 | $110K | 2 |
| Q3 2023 | $110K | 2 |
| Q4 2023 | $110K | 2 |
| Q1 2024 | $110K | 2 |
| Q2 2024 | $110K | 2 |
| Q3 2024 | $110K | 2 |
| Q4 2024 | $110K | 2 |
| Q1 2025 | $110K | 2 |
| Q2 2025 | $110K | 2 |
| Q3 2025 | $110K | 2 |
| Q4 2025 | $110K | 2 |
| Q1 2026 | $90K | 2 |
| Q2 2026 | $90K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$920K · 22 reports
- Health issues$470K · 14 reports
- Budget and appropriations$90K · 2 reports
- Medicare and Medicaid$30K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES28 reports
- SENATE23 reports
- Food & Drug Administration (FDA)3 reports
- Health & Human Services, Dept of (HHS)3 reports
- Office of Natl Drug Control Policy (NDCP)1 reports
Firms it paid
| Firm | ||
|---|---|---|
| Government Counsel | $860K | 15 quarters |
| Radius Advocacy | $650K | 13 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BENJAMIN STAUB | Professional Staff, House Judiciary Committee | Q2 2026 |
| CARLYLE THORSEN | General Counsel, Rep. Tom DeLay; Deputy Asst. Attorney General, Dept. of Justice; Counsel, House Judiciary Committee; Legislative Counsel, Rep. McCollum and LoBiondo | Q2 2026 |
| HENRY W MENN iii | Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner. | Q2 2026 |
| JAMES FRENCH | Counsel, House Judiciary Committee | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 10/01for Q3 | Akin Gump Strauss Hauer & Feld | Under $5,000 |
| 07/19for Q2 | Radius Advocacy | $50K |
| 07/19for Q2 | Radius Advocacy | $50K |
| 07/17for Q2 | Government Counsel | $40K |
| 04/18for Q1 | Radius Advocacy | $50K |
| 04/17for Q1 | Government Counsel | $40K |
| 01/19for Q4 2025 | Government Counsel | $60K |
| 01/17for Q4 2025 | Radius Advocacy | $50K |
| 01/17for Q4 2025 | Radius Advocacy | $50K |
| 25/10/07for Q3 2025 | Radius Advocacy | $50K |
| 25/10/03for Q3 2025 | Government Counsel | $60K |
| 25/07/21for Q2 2025 | Radius Advocacy | $50K |
| 25/07/09for Q2 2025 | Government Counsel | $60K |
| 25/04/19for Q1 2025 | Radius Advocacy | $50K |
| 25/04/13for Q1 2025 | Government Counsel | $60K |
| 25/01/15for Q4 2024 | Radius Advocacy | $50K |
| 25/01/13for Q4 2024 | Government Counsel | $60K |
| 24/10/18for Q3 2024 | Government Counsel | $60K |
| 24/10/10for Q3 2024 | Radius Advocacy | $50K |
| 24/07/13for Q2 2024 | Radius Advocacy | $50K |